EcoDrugPlus

Prostaglandin-Endoperoxide Synthase 2

Ensembl ID : ENSUPAG00010003184
Gene Symbol: PTGS2
3 Cross references
236 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSUPAG00010005766
Gene Symbol: PSMA1
3 Cross references
254 Possible Orthologues:

Proteasome 20s Subunit Alpha 2

Ensembl ID : ENSUPAG00010015674
Gene Symbol: PSMA2
1 Cross references
227 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSUPAG00010000924
Gene Symbol: PSMA3
1 Cross references
225 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSUPAG00010023600
Gene Symbol: PSMA4
1 Cross references
241 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSUPAG00010015655
Gene Symbol: PSMA5
1 Cross references
209 Possible Orthologues:

Proteasome 20s Subunit Alpha 6

Ensembl ID : ENSUPAG00010001196
Gene Symbol: PSMA6
3 Cross references
277 Possible Orthologues:

Proteasome 20s Subunit Alpha 7

Ensembl ID : ENSUPAG00010008463
Gene Symbol: PSMA7
3 Cross references
151 Possible Orthologues:

Proteasome 20s Subunit Alpha 8

Ensembl ID : ENSUPAG00010012791
Gene Symbol: PSMA8
3 Cross references
197 Possible Orthologues:

Proteasome 20s Subunit Beta 1

Ensembl ID : ENSUPAG00010006708
Gene Symbol: PSMB1
1 Cross references
214 Possible Orthologues:

Proteasome 20s Subunit Beta 10

Ensembl ID : ENSUPAG00010000439
Gene Symbol: PSMB10
1 Cross references
171 Possible Orthologues:

Proteasome 20s Subunit Beta 2

Ensembl ID : ENSUPAG00010000458
Gene Symbol: PSMB2
3 Cross references
219 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).